Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Primary qHTS Assay for Inhibitors of Recombinant Selenoprotein Glutathione Peroxidase 1 (GPX1)
Assay data:186 Active, 9 Activity ≤ 1 µM, 11353 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
ICL Enzyme Assay from Article 10.3109/14756360903425221: "5-Nitro-2,6-dioxohexahydro-4-pyrimidinecarboxamides: synthesis, in vitro antimycobacterial activity, cytotoxicity, and isocitrate lyase inhibition studies."
Assay data:9 Tested
SummaryPubMed CitationRelated BioAssays by Target
Oatp1d1 Transport Assay from Article 10.1074/jbc.M113.518506: "Molecular characterization of zebrafish Oatp1d1 (Slco1d1), a novel organic anion-transporting polypeptide."
Assay data:13 Active, 2 Activity ≤ 1 µM, 30 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed Citation
Fluorometric Ub-AMC Hydrolysis Assay from Article 10.1021/acschembio.7b00543: "Cell Lysate-Based AlphaLISA Deubiquitinase Assay Platform for Identification of Small Molecule Inhibitors."
Assay data:4 Active, 7 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Drug screen in CRL1545 osteosarcoma cells to determine synergistic drug combinations that target childhood tumors with chromothripsis
Assay data:35 Active, 378 Tested
SummaryCompounds, ActiveRelated BioAssays by Depositor
Drug screen in RCMB18 medulloblastoma cells to determine synergistic drug combinations that target childhood tumors with chromothripsis
Assay data:10 Active, 378 Tested
Drug screen in BT084 (ICGC_MB145) medulloblastoma cells to determine synergistic drug combinations that target childhood tumors with chromothripsis
Assay data:9 Active, 378 Tested
Drug screen in Human astrocytes as non-malignant controls to determine synergistic drug combinations that target childhood tumors with chromothripsis
Assay data:23 Active, 378 Tested
Drug screen in UWB1.289_BRCA1 ovarian carcinoma cells to determine synergistic drug combinations that target childhood tumors with chromothripsis
Assay data:26 Active, 378 Tested
Drug screen in MDA-MB-436 breast carcinoma cells to determine synergistic drug combinations that target childhood tumors with chromothripsis
Assay data:4 Active, 378 Tested
Drug screen in LFS_MB_2R medulloblastoma cells to determine synergistic drug combinations that target childhood tumors with chromothripsis
Assay data:11 Active, 378 Tested
Drug screen in UWB1.289 ovarian carcinoma cells to determine synergistic drug combinations that target childhood tumors with chromothripsis
Assay data:14 Active, 378 Tested
Drug screen in HD-MB03 medulloblastoma cells to determine synergistic drug combinations that target childhood tumors with chromothripsis
Assay data:53 Active, 378 Tested
Drug screen in CRL2098 osteosarcoma cells to determine synergistic drug combinations that target childhood tumors with chromothripsis
Assay data:20 Active, 378 Tested
Drug screen in HTB85 osteosarcoma cells to determine synergistic drug combinations that target childhood tumors with chromothripsis
Assay data:38 Active, 378 Tested
Drug screen in LFS_MB_1R medulloblastoma cells to determine synergistic drug combinations that target childhood tumors with chromothripsis
Assay data:21 Active, 378 Tested
Drug screen in ICB984 medulloblastoma cells to determine synergistic drug combinations that target childhood tumors with chromothripsis
Assay data:378 Tested
SummaryRelated BioAssays by Depositor
Drug screen in HDN33 neuroblastoma cells to determine synergistic drug combinations that target childhood tumors with chromothripsis
Assay data:32 Active, 378 Tested
Drug screen in LFS_MB_P medulloblastoma cells to determine synergistic drug combinations that target childhood tumors with chromothripsis
Primary qHTS to identify inhibitors of SARS-CoV-2 cell entry
Assay data:368 Active, 78 Activity ≤ 1 µM, 5114 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Depositor
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on